One-Fourth of Myriad’s Variants of Unknown Significance Reclassified Over 10 Years
From - Diagnostic Testing & Emerging Technologies Variant reclassification following hereditary cancer genetic testing is common, according to a study published by… . . . read more
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article